182 related articles for article (PubMed ID: 19122165)
1. Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cbeta2 in the regulation of physiologic developmental hypertrophy and heart function.
Rigor DL; Bodyak N; Bae S; Choi JH; Zhang L; Ter-Ovanesyan D; He Z; McMullen JR; Shioi T; Izumo S; King GL; Kang PM
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H566-72. PubMed ID: 19122165
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling.
Liu Y; Jin J; Qiao S; Lei S; Liao S; Ge ZD; Li H; Wong GT; Irwin MG; Xia Z
Clin Sci (Lond); 2015 Aug; 129(4):331-44. PubMed ID: 25849791
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia-induced protein kinase C β2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling.
Lei S; Li H; Xu J; Liu Y; Gao X; Wang J; Ng KF; Lau WB; Ma XL; Rodrigues B; Irwin MG; Xia Z
Diabetes; 2013 Jul; 62(7):2318-28. PubMed ID: 23474486
[TBL] [Abstract][Full Text] [Related]
4. Basal and IGF-I-dependent regulation of potassium channels by MAP kinases and PI3-kinase during eccentric cardiac hypertrophy.
Teos LY; Zhao A; Alvin Z; Laurence GG; Li C; Haddad GE
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H1834-45. PubMed ID: 18757484
[TBL] [Abstract][Full Text] [Related]
5. FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
Weeks KL; Tham YK; Yildiz SG; Alexander Y; Donner DG; Kiriazis H; Harmawan CA; Hsu A; Bernardo BC; Matsumoto A; DePinho RA; Abel ED; Woodcock EA; McMullen JR
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1470-H1485. PubMed ID: 33577435
[TBL] [Abstract][Full Text] [Related]
6. Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.
McMullen JR; Shioi T; Zhang L; Tarnavski O; Sherwood MC; Kang PM; Izumo S
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12355-60. PubMed ID: 14507992
[TBL] [Abstract][Full Text] [Related]
7. Association of PI3K-Akt signaling pathway with digitalis-induced hypertrophy of cardiac myocytes.
Liu L; Zhao X; Pierre SV; Askari A
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1489-97. PubMed ID: 17728397
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide dependent protein kinase 1 is required for exercise-induced cardiac hypertrophy but not the associated mitochondrial adaptations.
Noh J; Wende AR; Olsen CD; Kim B; Bevins J; Zhu Y; Zhang QJ; Riehle C; Abel ED
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):297-305. PubMed ID: 26476238
[TBL] [Abstract][Full Text] [Related]
9. In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts.
Takeishi Y; Chu G; Kirkpatrick DM; Li Z; Wakasaki H; Kranias EG; King GL; Walsh RA
J Clin Invest; 1998 Jul; 102(1):72-8. PubMed ID: 9649559
[TBL] [Abstract][Full Text] [Related]
10. Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32347291
[TBL] [Abstract][Full Text] [Related]
11. The acute phase protein alpha2-macroglobulin induces rat ventricular cardiomyocyte hypertrophy via ERK1,2 and PI3-kinase/Akt pathways.
Padmasekar M; Nandigama R; Wartenberg M; Schlüter KD; Sauer H
Cardiovasc Res; 2007 Jul; 75(1):118-28. PubMed ID: 17412314
[TBL] [Abstract][Full Text] [Related]
12. Complex regulation of PKCβ2 and PDK-1/AKT by ROCK2 in diabetic heart.
Lin G; Brownsey RW; Macleod KM
PLoS One; 2014; 9(1):e86520. PubMed ID: 24466133
[TBL] [Abstract][Full Text] [Related]
13. Pik3ip1 modulates cardiac hypertrophy by inhibiting PI3K pathway.
Song HK; Kim J; Lee JS; Nho KJ; Jeong HC; Kim J; Ahn Y; Park WJ; Kim DH
PLoS One; 2015; 10(3):e0122251. PubMed ID: 25826393
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats.
Xia Z; Kuo KH; Nagareddy PR; Wang F; Guo Z; Guo T; Jiang J; McNeill JH
Cardiovasc Res; 2007 Mar; 73(4):770-82. PubMed ID: 17250813
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with insulin-like growth factor I enhances myocyte contraction by upregulation of Akt-SERCA2a signaling pathway.
Kim SJ; Abdellatif M; Koul S; Crystal GJ
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H130-5. PubMed ID: 18456736
[TBL] [Abstract][Full Text] [Related]
16. H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.
Matsuda T; Jeong JI; Ikeda S; Yamamoto T; Gao S; Babu GJ; Zhai P; Del Re DP
Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193718
[TBL] [Abstract][Full Text] [Related]
17. CpG-ODN attenuates pathological cardiac hypertrophy and heart failure by activation of PI3Kα-Akt signaling.
Yang L; Cai X; Liu J; Jia Z; Jiao J; Zhang J; Li C; Li J; Tang XD
PLoS One; 2013; 8(4):e62373. PubMed ID: 23638055
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.
Chandrasekar B; Mummidi S; Claycomb WC; Mestril R; Nemer M
J Biol Chem; 2005 Feb; 280(6):4553-67. PubMed ID: 15574430
[TBL] [Abstract][Full Text] [Related]
19. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
Evans-Anderson HJ; Alfieri CM; Yutzey KE
Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
[TBL] [Abstract][Full Text] [Related]
20. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
